Greenleaf Peter
Insider CIK 1363683 · ATRS Director · BDSI Director · MSTX Director · SCMP Chief Executive Officer, Director · EYEG Director · MIRN Director · CERC Chief Executive Officer, Director · AUPH Chief Executive Officer, Director · PTHS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-10-02 | 2026-10-06 | 797 | $21.17 | $16.9K | 23,087 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-07-02 | 2026-07-07 | 85 | $27.27 | $2.3K | 23,884 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-07-02 | 2026-07-07 | 712 | $26.00 | $18.5K | 23,969 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-04-02 | 2026-04-06 | 377 | $21.36 | $8.1K | 24,681 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | S Sale | 2026-04-02 | 2026-04-06 | 420 | $20.52 | $8.6K | 25,058 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-03-02 | 2026-03-03 | 100,890 | $14.21 | $1.43M | 1,840,379 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2026-02-27 | 2026-03-03 | 328,424 | — | $0 | 328,424 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2026-02-27 | 2026-03-03 | 196,403 | — | $0 | 1,941,269 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-02-20 | 2026-02-23 | 100,171 | $14.40 | $1.44M | 1,744,866 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2026-01-02 | 2026-01-05 | 165,384 | — | $0 | 1,954,329 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-01-02 | 2026-01-05 | 113,169 | $15.95 | $1.81M | 1,845,037 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award | 2025-07-02 | 2026-04-01 | 25,478 | — | $0 | 25,478 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 25,478 | — | $0 | 25,478 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-07-02 | 2025-07-07 | 77,640 | — | $0 | 77,640 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2025-03-04 | 2025-03-04 | 164,947 | $7.92 | $1.31M | 1,788,945 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2025-03-03 | 2025-03-04 | 333,705 | — | $0 | 2,149,485 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2025-03-03 | 2025-03-04 | 195,593 | $8.00 | $1.56M | 1,953,892 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2025-02-28 | 2025-03-04 | 443,973 | — | $0 | 443,973 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2025-02-28 | 2025-03-04 | 290,728 | — | $0 | 1,815,780 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2024-03-06 | 2024-03-07 | 126,981 | $5.60 | $711.1K | 1,522,114 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2024-02-20 | 2024-02-22 | 661,538 | — | $0 | 1,649,095 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2023-03-02 | 2024-02-22 | 33,047 | $8.78 | $290.2K | 982,671 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2023-03-02 | 2023-03-06 | 667,407 | — | $0 | 1,015,718 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2023-03-02 | 2023-03-06 | 32,750 | $8.94 | $292.8K | 982,968 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 48,542 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 58,246 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 46,729 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 30,220 | $5.60 | $169.2K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 49,425 | $5.60 | $276.8K | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 27,746 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 114,347 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | D To issuer deriv | 2022-03-22 | 2022-03-22 | 64,164 | — | $0 | 0 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | J Other | 2022-03-22 | 2022-03-22 | 105,034 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-03-02 | 2022-03-04 | 534,188 | — | $0 | 534,188 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-03-02 | 2022-03-04 | 312,240 | — | $0 | 312,240 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2022-03-02 | 2022-03-04 | 9,068 | $12.01 | $108.9K | 32,967 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2022-03-02 | 2022-03-04 | 28,300 | — | $0 | 42,035 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-01-31 | 114,347 | $3.66 | $418.5K | 114,347 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2022-01-27 | 2022-01-31 | 20,492 | — | $0 | 20,492 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2022-01-27 | 2022-01-31 | 10,246 | — | $0 | 10,246 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2022-01-27 | 2022-01-31 | 10,246 | — | $0 | 105,034 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2021-08-06 | 2021-08-10 | 35,000 | — | $0 | 17,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2021-08-06 | 2021-08-10 | 35,000 | — | $0 | 94,788 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 48,542 | — | $0 | 48,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 25,452 | $4.42 | $112.5K | 79,645 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | P Buy | 2021-05-11 | 2021-05-12 | 2,992 | $11.11 | $33.2K | 13,453 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | P Buy | 2021-05-11 | 2021-05-12 | 2,133 | $10.15 | $21.6K | 10,461 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2020-08-07 | 2020-08-11 | 35,000 | — | $0 | 52,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2020-08-07 | 2020-08-11 | 35,000 | — | $0 | 59,788 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 58,246 | — | $0 | 58,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 30,220 | $2.73 | $82.5K | 54,193 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2019-08-13 | 2019-08-15 | 21,144 | — | $0 | 87,500 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2019-08-13 | 2019-08-15 | 21,144 | — | $0 | 24,788 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2019-08-07 | 2019-10-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 46,729 | — | $0 | 46,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 23,973 | $2.92 | $70.0K | 23,973 | SEC↗ |
| CERC Cerecor Inc. | D To issuer deriv | 2019-05-24 | 2019-05-29 | 325,000 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | D To issuer deriv | 2019-05-24 | 2019-05-29 | 364,583 | — | $0 | 135,417 | SEC↗ |
| CERC Cerecor Inc. | D To issuer deriv | 2019-05-24 | 2019-05-29 | 500,000 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | D To issuer | 2019-05-24 | 2019-05-29 | 300,000 | — | $0 | 112,500 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2019-04-01 | 2019-04-02 | 325,000 | — | $0 | 325,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2019-02-01 | 2019-02-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-12-13 | 2018-12-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2018-08-14 | 2018-08-16 | 3,644 | — | $0 | 108,644 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2018-08-14 | 2018-08-16 | 3,644 | — | $0 | 3,644 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 112,288 | — | $0 | 112,288 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2018-08-01 | 2018-08-03 | 64,164 | — | $0 | 64,164 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2018-07-27 | 2018-08-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CERC Cerecor Inc. | P Buy | 2018-05-18 | 2018-05-21 | 12,500 | $3.98 | $49.8K | 412,500 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2018-03-27 | 2018-03-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2018-03-27 | 2018-03-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CERC Cerecor Inc. | A Award | 2018-03-27 | 2018-03-29 | 400,000 | — | $0 | 400,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 600,000 | $9.51 | $5.71M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 237,000 | $6.15 | $1.46M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 420,000 | $4.20 | $1.76M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 210,000 | $3.18 | $667.8K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 200,000 | $12.10 | $2.42M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 129,729 | $18.00 | $2.34M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-12-31 | 2018-01-04 | 171 | $9.10 | $1.6K | 4,792 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-09-30 | 2017-10-05 | 659 | $9.10 | $6.0K | 4,621 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2017-06-30 | 2017-07-31 | 8,357 | — | $0 | 8,357 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-30 | 2017-07-07 | 673 | $8.93 | $6.0K | 3,962 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2017-05-12 | 2017-05-16 | 16,714 | — | $0 | 16,714 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-31 | 2017-05-10 | 641 | $9.35 | $6.0K | 3,289 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-03-06 | 2017-03-08 | 237,000 | — | $0 | 1,667,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-06 | 2017-03-08 | 125,000 | — | $0 | 125,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2017-01-20 | 2017-01-23 | 45,535 | — | $0 | 45,535 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-12-31 | 2017-01-06 | 135 | $10.46 | $1.4K | 2,648 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2016-11-29 | 2016-11-30 | 82,459 | — | $0 | 1,430,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2016-11-29 | 2016-11-30 | 82,459 | $16.75 | $1.38M | 2,513 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2016-11-29 | 2016-11-30 | 82,459 | $6.75 | $556.6K | 84,972 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2016-11-28 | 2016-11-30 | 117,541 | — | $0 | 1,512,459 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2016-11-28 | 2016-11-30 | 117,541 | $16.91 | $1.99M | 2,513 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2016-11-28 | 2016-11-30 | 117,541 | $6.75 | $793.4K | 120,054 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-09-30 | 2016-10-21 | 640 | $9.38 | $6.0K | 2,513 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-06-30 | 2016-07-18 | 751 | $9.32 | $7.0K | 1,873 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-06-29 | 2016-09-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2016-06-15 | 2016-06-17 | 79,551 | — | $0 | 79,551 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-03-31 | 2016-06-16 | 646 | $9.29 | $6.0K | 1,122 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-03-11 | 2016-03-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2016-03-02 | 2016-03-04 | 420,000 | — | $0 | 1,630,000 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | A Award deriv | 2016-03-01 | 2016-03-02 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2015-12-31 | 2016-03-04 | 476 | $14.70 | $7.0K | 476 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2015-11-05 | 2015-11-09 | 37,794 | — | $0 | 37,794 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2015-11-05 | 2015-11-09 | 64,791 | — | $0 | 64,791 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-03-04 | 2015-03-13 | 210,000 | — | $0 | 1,210,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-09-11 | 2014-09-15 | 200,000 | — | $0 | 1,000,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-07-31 | 2014-08-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-03-03 | 2014-03-05 | 600,000 | — | $0 | 600,000 | SEC↗ |